Results 51 to 60 of about 24,154 (255)

Bayesian multi-modal model comparison: a case study on the generators of the spike and the wave in generalized spike–wave complexes [PDF]

open access: yes, 2010
We present a novel approach to assess the networks involved in the generation of spontaneous pathological brain activity based on multi-modal imaging data.
Daunizeau, J.   +2 more
core   +1 more source

The prognosis of idiopathic generalized epilepsy [PDF]

open access: yesEpilepsia, 2012
SummaryPrognosis describes the trajectory and long‐term outcome of a condition. Most studies indicate a better prognosis in idiopathic generalized epilepsy (IGE) in comparison with other epilepsy syndromes. Studies looking at the long‐term outcome of different IGE syndromes are relatively scant.
Udaya, Seneviratne   +2 more
openaire   +2 more sources

SV2A expression in blood cells as a possible biomarker candidate for levetiracetam treatment response

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to evaluate whether synaptic vesicle protein 2A (SV2A) expression on peripheral immune cells predicts treatment response to levetiracetam in epilepsy. Methods High‐dimensional flow cytometry was used to prospectively assess SV2A expression on immune cells from levetiracetam responders, nonresponders, and ...
Johannes Lang   +4 more
wiley   +1 more source

Effects of patient and seizure-related factors on drug load in seizure-free patients with idiopathic generalized epilepsy

open access: yesNeurological Sciences and Neurophysiology, 2021
Introduction: Idiopathic generalized epilepsies (IGEs) include four different epilepsy syndromes and IGE have mostly a good response to antiepileptic drugs (AEDs). The most common IGE subgroup is juvenile myoclonic epilepsy (JME).
Fulya Eren, Günay Gül
doaj   +1 more source

Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs

open access: yesEpilepsia, EarlyView.
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin   +7 more
wiley   +1 more source

Ictal pain: occurrence, clinical features, and underlying etiologies. [PDF]

open access: yes, 2016
PURPOSE: We analyzed a series of patients with ictal pain to estimate its occurrence and characterize the underlying etiologies. METHODS: We retrospectively reviewed all the long-term video-EEG reports from Jefferson Comprehensive Epilepsy Center over a ...
Asadi-Pooya, Ali Akbar   +2 more
core   +2 more sources

Patterns of seizure frequency reduction in clinical trial participants with lower baseline seizure frequency

open access: yesEpilepsia, EarlyView.
Abstract Objective Inclusion and exclusion criteria of clinical trials for seizures aim to select representative participants with a high enough seizure frequency to evaluate the efficacy of treatment in a relatively short double‐blind period. To inform the selection of seizure frequency‐based inclusion criteria, we evaluated the association between ...
Wesley T. Kerr   +5 more
wiley   +1 more source

Concurrent language disorders in children with idiopathic epilepsy

open access: yesThe Egyptian Journal of Otolaryngology, 2017
Objectives The relationship between language and epilepsy remains complex. Language disorder and epilepsy can be concomitant but unrelated phenomena. They can also be separate consequences of the same underlying brain pathology.
Hamdy M. Bedair   +3 more
doaj   +1 more source

IDIOPATHIC PARTIAL EPILEPSY WITH AUDITORY FEATURES (IPEAF): A CLINICAL AND GENETIC STUDY OF 53 SPORADIC CASES [PDF]

open access: yes, 2004
The purpose of our study was to describe the clinical characteristics of sporadic (S) cases of partial epilepsy with auditory features (PEAF) and pinpoint clinical, prognostic and genetic differences with respect to previously reported familial (F ...
AVONI P   +13 more
core  

Levetiracetam in clinical practice: efficacy and tolerability in epilepsy. [PDF]

open access: yes, 2010
BACKGROUND: The aim of this study was to evaluate efficacy and tolerability of levetiracetam (LEV) in patients with different epilepsy syndromes. METHODS: We evaluated epileptic patients seen in the previous 18 months, including all patients with present
BILO, LEONILDA, de Leva MF, Meo R.
core   +1 more source

Home - About - Disclaimer - Privacy